In fact, Siglec‐14 has been shown to counteract the exploitation of Siglec‐5 by GBS (Ali et al., 2014), and Siglec‐16 reduces survival of E. coli K1 during infection (Schwarz et al., 2017). Here, SIGLEC5 is linked to infection.